Merck CEO tells CNBC he expects breakthrough cancer vaccine will become faster to make

Merck CEO Rob Davis told CNBC that he expects the company's breakthrough cancer vaccine with Moderna to get faster to make over time. Davis acknowledged that manufacturing the vaccine is a "complex sy...

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。